Teplizumab, An Emerging Therapy for Preventing Progression of Type 1 Diabetes
ACPE Activity Number:0204-0000-25-048-H01-P Release Date:06/26/2025 Expiration Date:06/26/2028 Activity Type: Knowledge-based CE Credits: 1 contact hour Activity Fee: Member – Free / Non-Member – Not Available
Activity Overview
Join experts as they provide the evidence for the safety and efficacy of a new monoclonal antibody which received FDA approval in 2022 to delay the onset of Stage 3 type 1 diabetes in adults and pediatric patients.
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.
In accordance with our accreditor’s Standards of Integrity and Independence in Accredited Continuing Education, ASHP requires that all individuals in control of content disclose all financial relationships with ineligible companies. An individual has a relevant financial relationship if they have had a financial relationship with an ineligible company in any dollar amount in the past 24 months and the educational content that the individual controls is related to the business lines or products of the ineligible company.
An ineligible company is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The presence or absence of relevant financial relationships will be disclosed to the activity audience.
No one in control of the content of this activity has a relevant financial relationship (RFR) with an ineligible company.
Per ACPE requirements, CPE credit must be claimed within 60 days of being earned. Once you have processed and claimed your CE credit, we encourage you to check your NABP eProfile account to verify your credits were transferred successfully before the ACPE 60-day deadline. It is an electronic direct-report process so your credits should appear in your account within a few minutes. After the 60 day deadline, ASHP will no longer be able to report your credit(s) for this activity.
